IHH Healthcare - Litigation With Emqore
- IHH Healthcare (SGX:Q0F) today revealed that Emqore has filed a suit against it and 47 others seeking damages of > US$6.5bn related to the issuance of Fortis shares.
- IHH Healthcare said it has strong grounds to dismiss the suit and will file a motion for it.
- Reiterate ADD call on IHH Healthcare with SOP-based target price of RM8.30. We like IHH Healthcare for its diversified and resilient earnings.
- While the lira’s depreciation will impact its earnings arising from IHH Healthcare’s operations in Turkey, it is mainly forex translation losses.
Above is the excerpt from research report by CGS-CIMB.
Clients of CGS-CIMB may access the full report in PDF @ https://www.itradecimb.com.sg/.
EING Kar Mei CFA CGS-CIMB Research | TAY Wee Kuang CGS-CIMB Research | https://www.cgs-cimb.com 2022-01-06 2022-01-06
Read also CGS-CIMB's most recent report:
2022-06-08 IHH Healthcare - Positive On International Medical University (IMU) Sale
Check out the most recent target prices at IHH Healthcare Target Prices. Listing of analyst research reports at IHH Healthcare Analyst Report.
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividends & Corp Actions,
IHH Healthcare News Articles